AzTrials
AzTrials

Clinical trials: Mild to Moderate Acne

What
Where
Study
Who can join
Dates
Clear all

0 studies

  • Acne Vulgaris

    Sebacia Postmarket Study of Real-World Use

    • Unknown status
    • Age: 12 to 45 years

    Postmarket study of Sebacia Microparticles treatment during adoption into clinical use for patients with mild to moderate inflammatory acne vulgaris.

    Trial name
    NCT03818555
    Testing
    Sebacia Microparticles Treatment
    Where
    6 sites in United States
    Volunteers
    125 people
    Sponsor
    Sebacia, Inc.
    Can I take part? NCT03818555

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in